Patient & Survivor Care
Feature
Increased cancer in military pilots and ground crew: Pentagon
But military aircrew and ground crew were less likely to die from cancer, compared with the U.S. population.
News from the FDA/CDC
FDA strengthens mammography regulations: Final rule
A final rule requires that mammography facilities notify patients about the density of their breasts.
From the Journals
Breast cancer surgery timing matters, but is faster always better?
There are no national quality metrics delineating optimal breast cancer surgery timing.
Latest News
HER2-low breast cancer is not a separate clinical entity: Study
Much attention has been focused recently on the idea that breast cancer with a low expression of HER2 can be treated with HER2-targeted agents,...
News from the FDA/CDC
FDA expands abemaciclib use in high-risk early breast cancer
The new expansion removes the Ki-67 testing requirement.
From the Journals
Who’s at higher risk for breast cancer recurrence?
New research shows that patients with ER-negative disease have a higher risk of a second breast cancer within a 5-year window post diagnosis,...
Feature
Myths about smoking, diet, alcohol, and cancer persist
A new study shows how thinking has changed over time and how difficult it is to alter preconceived notions.
Conference Coverage
Rucaparib benefit in BRCA+ prostate cancer confirmed
New study finding provides evidence of clinical benefit for an indication for rucaparib that was granted an accelerated approval in May 2020.
From the Journals
Factors linked to higher risk for death in young cancer survivors
Study indicates that treating chronic health conditions alone may not be enough to increase a cancer survivor’s lifespan.
From the Journals
Omit radiation in older women with low-risk, ER+ breast cancer
Trial randomly assigns 1,326 women who had undergone a lumpectomy to either whole-breast irradiation or no radiation on a background of tamoxifen...
Commentary
Local therapies show promise for metastatic lung cancer
Local therapy for colorectal cancer with limited liver-only metastases is now established as a path to potentially excellent long-term survival....